Diagnosis

Mononucleosis

An acute and self-limited infection of the lymphatic system characterized by sore throat (pharyngitis), cervical lymphadenopathy, fatigue and fever.

Also known as: EBV, Epstein–Barr virus, Glandular fever

Etiology

Cause [crs][b87][esg][qqd]

Pathophysiology

  1. Virus is transmitted via intimate contact with body (oropharyngeal) secretions

  2. Incubation period is long: 3-6 weeks

  3. EBV infects the B cells in the oropharyngeal epithelium. Circulating B cells spread the infection to liver, spleen, and peripheral lymph nodes

  4. This results in a humoral and cellular response to the virus

  5. T-lymphocyte response is essential in the control of EBV infection; natural killer (NK) cells and predominantly CD8 cytotoxic T cells control proliferating B lymphocytes infected with EBV

  6. EBV is a lifelong infection with periodic reactivation

  7. The majority of patients recover without sequelae and develop lifelong immunity to controlling the dormant virus

  8. Ineffective T-cell response (immunosuppresion) may result in excessive and uncontrolled B-cell proliferation, resulting in B-cell lymphomas

Complications [n8g][qqd]

Epidemiology

Incidence per 100.000 [bc8][ddo][esg][bsy][hp7][du5][3az][n8g][zvp][1ps][qqd]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Arthralgia, Confusion, Fatigue, Fever, Headache, Hepatomegaly, Lymphadenopathy, Malaise, Myalgia, Nausea, Odynophagia, Petechia, Sore throat, Splenomegaly

Clinical findings

Atypical lymphocytes, Elevated ALAT, Elevated ASAT, Elevated Bilirubin, Jaundice, Leukocytosis, Monospot, Thrombocytopenia

Anamneses

None listed.

Localized findings

Pain
Radiates
Throat (pharynx and larynx)
Onset
Gradual (days)
Pattern
Constant
Provoked by
Swallowing
Severity
Mild (1-3)Moderate (4-7)
Rash
Radiates
Cavum oris (inside mouth)
Distribution
MultipleSymmetric
Lesion type
Petechia
Color
Red
Associated symptom
PainSwelling
Swelling
Radiates
Tonsil
Onset
Gradual (days)
Pattern
Constant

Approach

Treatment

  1. There is no specific treatment for infectious mononucleosis [qqd]

  2. Supportive care:

    • Hydration

    • Rest

    • Nutritional intake

    • NSAIDs, paracetamol, throat sprays to treat fever, sore throat, and fatigue

  3. No clinical evidence regarding acyclovir, valacyclovir, ganciclovir, or corticosteroids

  4. Antibiotics can result in a generalized maculopapular rash

  5. Hospitalization if complications: splenic rupture, airway compromise, dehydration, thrombocytopenia, hemolytic anemia, and neurologic complications.

Differential diagnoses

Adenovirus, Bacterial tonsillitis, Cytomegalovirus, Depression, Diphtheria, Drug eruptions, Encephalitis, Erythema multiforme, Fibromyalgia, Gianotti-Crosti syndrome, Guillain-Barre syndrome, Hemophagocytic lymphohistiocytosis, Herpes simplex, HIV, Influenza, Leukemia, Lyme disease, Meningitis, Mumps, Peritonsillar abscess, Pharyngitis, Posttransplant lymphoproliferative disorder, Rickettsia, Rubella, Scarlet fever, Splenic injury, Toxoplasmosis, Viral hepatitis


References

[1] Mohseni M, Boniface MP, Graham C. Mononucleosis. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470387/

[2] https://emedicine.medscape.com/article/784513

[3] Morris MC, Edmunds WJ. The changing epidemiology of infectious mononucleosis? J Infect. 2002 Aug;45(2):107-9.

[4] https://emedicine.medscape.com/article/963894

[5] Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015;390(Pt 1):211-40.

[6] Kuri, A., Jacobs, B.M., Vickaryous, N. et al. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health 20, 912 (2020).

[7] Hubble MP, Lai PK, Mackay-Scollay M, Alpers MP. Epidemiology of infectious mononucleosis in Western Australia: A retrospective hospital survey, 1966-1972. Med J Aust. 1974 Dec 14;2(24):863-6.

[8] Stahlman S, Williams VF, Ying S. Infectious mononucleosis, active component, U.S. Armed Forces, 2002-2018. MSMR. 2019 Jul;26(7):28-33.

[9] Hunt G, Brady MT. Chapter 311. Epstein-Barr Virus Mononucleosis. In: Rudolph CD, Rudolph AM, Lister GE, First LR, Gershon AA. eds. Rudolph's Pediatrics, 22e. The McGraw-Hill Companies; 2011. Accessed December 19, 2024.

[10] Williams-Harmon YJ, Jason LA, Katz BZ. Incidence of Infectious Mononucleosis in Universities and U.S. Military Settings. J Diagn Tech Biomed Anal. 2016 Jun;5(1):10.4172/2469-5653.1000113.

[11] Leung AKC, Lam JM, Barankin B. Infectious Mononucleosis: An Updated Review. Curr Pediatr Rev. 2024;20(3):305-322.

[12] Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, Fukayama M, Mori S. Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol Int. 2006 Mar;56(3):112-6.

[13] Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis. 2013 Oct 15;208(8):1286-93.

Scroll to top